IFNB1 and myeloid sarcoma: 6 target pathways and 73 target genes (61 up-regulated target genes and 12 down-regulated target genes) were obtained by analyzing PBMC transcriptomic data from MS patients without treatment and before and after the application of IFN-β treatment.